Moolec Science Sa Stock Today

MLECW Stock   0.02  0.0009  6.08%   

Performance

Insignificant

 
Weak
 
Strong

Odds Of Distress

Very High

 
High
 
Low
Moolec Science is selling for under 0.0157 as of the 20th of July 2025; that is 6.08 percent up since the beginning of the trading day. The stock's lowest day price was 0.0157. Moolec Science has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 21st of April 2025 and ending today, the 20th of July 2025. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
IPO Date
3rd of January 2023
Category
Healthcare
Classification
Health Care
Moolec Science is entity of United States. It is traded as Stock on NASDAQ exchange. More on Moolec Science SA

Moving against Moolec Stock

  0.42FATE Fate TherapeuticsPairCorr
  0.34BCH Banco De ChilePairCorr

Moolec Stock Highlights

CEO CoFounderGaston MBA
Business ConcentrationBiotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors)
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.07980.15
Way Down
Slightly volatile
Total Current LiabilitiesM9.4 M
Way Down
Slightly volatile
Total Assets42 M40 M
Sufficiently Up
Slightly volatile
Total Current Assets16.6 M15.8 M
Sufficiently Up
Slightly volatile
Debt Levels
Moolec Science can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Moolec Science's financial leverage. It provides some insight into what part of Moolec Science's total assets is financed by creditors.
Liquidity
Moolec Science SA has accumulated 14.68 M in total debt. Note, when we think about Moolec Science's use of debt, we should always consider it together with its cash and equity.

End Period Cash Flow

6.51 Million
Moolec Science SA (MLECW) is traded on NASDAQ Exchange in USA. It is located in , United Kingdom and employs 8 people. Moolec Science is listed under Biotechnology category by Fama And French industry classification. The company classifies itself under Biotechnology sector and is part of Health Care industry. Moolec Science generates negative cash flow from operations
Check Moolec Science Probability Of Bankruptcy

Moolec Science Historical Income Statement

At this time, Moolec Science's Cost Of Revenue is fairly stable compared to the past year. Reconciled Depreciation is likely to climb to about 1.2 M in 2025, whereas EBIT is likely to drop (6.8 M) in 2025. View More Fundamentals

Moolec Stock Against Markets

Moolec Science Corporate Management

Florencia BotteroCorporate BoardProfile
Agustin FalusGlobal ControllerProfile
Jose MBAChief OfficerProfile
Amit DhingraChief OfficerProfile

Additional Tools for Moolec Stock Analysis

When running Moolec Science's price analysis, check to measure Moolec Science's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Moolec Science is operating at the current time. Most of Moolec Science's value examination focuses on studying past and present price action to predict the probability of Moolec Science's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Moolec Science's price. Additionally, you may evaluate how the addition of Moolec Science to your portfolios can decrease your overall portfolio volatility.